Kolexia
Godot Cecile
Pédiatrie
Hôpital Necker Enfants Malades
Paris, France
50 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Diabète Diabète de type 1 Maladies néonatales Hypoglycémie Albinisme Maladie chronique Métastase tumorale Méningite à pneumocoques Empyème

Industries

Lilly
12 collaboration(s)
Dernière en 2023
Sanofi
1 collaboration(s)
Dernière en 2023
DMEDICA
1 collaboration(s)
Dernière en 2021
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

DBL4T: An Open-label, Multicenter, Randomized, Crossover Study, to Assess 4 Weeks Outpatient, the Clinical Efficacy of the Diabeloop Closed-loop Glucose Control Without the Declaration of Meals Compared With the Diabeloop Closed-loop Glucose Control With the Declaration of Meals, in Adolescent Patients With Type 1 Diabetes Poorly Controlled.
Essai Clinique (Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète)   16 février 2023
Visio ETP: Qualitative Phenomenological Study on Remote Therapeutic Education by Videoconferencing Crossing the Participant and Caregiver View
Essai Clinique (Assistance publique – Hôpitaux de Paris)   16 janvier 2023
Mitchell-Riley Syndrome: Improving Clinical Outcomes and Searching for Functional Impact of RFX-6 Mutations.
Frontiers in endocrinology   22 juin 2022
DISEPEIN: Validation of an Educational Evaluation Plan and Assessment of Its Usefulness in Therapeutic Patient Education: Case of Pediatric Home Parenteral Nutrition
Essai Clinique (Assistance publique – Hôpitaux de Paris)   07 juin 2022
Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial.
The Lancet. Digital health   25 avril 2022
Development and co-construction of a therapeutic patient education program for albinism.
Annales de dermatologie et de venereologie   30 juin 2021
Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial.
PloS one   15 mars 2021
Life-Saving, Dose-Adjusted, Targeted Therapy in a Patient with a STAT3 Gain-of-Function Mutation.
Journal of clinical immunology   11 janvier 2021
Co-construction d’un programme d’éducation thérapeutique dédié à l’albinisme
JDP 2020   01 décembre 2020
DBL4K: An Open-label, Three-center, Randomized, Two-session, Crossover Study, to Assess 4 Days Inpatient, and 6-week Follow-up Home Study Phase Under Remote Monitoring at Only French Centers, the Efficacy and the Safety of the Diabeloop Closed-loop Glucose Control Compared With Sensor-augmented Pump Therapy, in Young Children With Type 1 Diabetes.
Essai Clinique (Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète)   05 mars 2020